Quick sums for PXS -
$62 million market cap at 20c
- $23 million in the bank from last quarterly
- $39 million upfront from BI.
= $62 million
Plus all extra payments if everything goes right with the drug - $278 AUD million.
If this was to go through the SP equivalent to cash would be around $1.08
Not included in this, is the deal with Chiesi for PXS's other drug Brontichol. Where they will be producing the drug for Chiesi and if Chiesi decided to produce it themselves will have to pay royalites to PXS. Also add in future sales of this drug, extra milestone payments as stated in the news release (equivalent to the milestones above 200+ million). This could be one to hold for the long term, or for a great day trade today!
